Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

35.66
Delayed Data
As of May 22
 -0.18 / -0.50%
Today’s Change
19.51
Today|||52-Week Range
73.72
-43.78%
Year-to-Date
Is Arrowhead Pharmaceuticals a Buy?
May 24 / MotleyFool.com - Paid Partner Content
Will Arrowhead Pharmaceuticals Be a Biotech Winner?
May 19 / MotleyFool.com - Paid Partner Content
Is Alnylam Pharmaceuticals a Buy?
May 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close35.84
Today’s open35.79
Day’s range34.87 - 35.84
Volume57,948
Average volume (3 months)1,588,921
Market cap$3.6B
Data as of 4:00pm ET, 05/22/2020

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-172.86%
Earnings growth (next 5 years)--
Revenue growth (last year)+945.67%
P/E ratio396.2
Price/Sales16.46
Price/Book13.96

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...+0.58+0.90%
MNTAMomenta Pharmaceutic...+0.54+1.68%
HALOHalozyme Therapeutic...+0.15+0.61%
DCPHDeciphera Pharmaceut...-0.44-0.74%
Data as of 4:00pm ET, 05/22/2020

Financials

Next reporting dateAugust 11, 2020
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$168.8M
Annual profit (last year)$68.0M
Net profit margin40.27%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Pasadena, California

Forecasts